about
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomySulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein DishevelledThe evolving biology and treatment of prostate cancer.Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Exisulind in the treatment of prostate cancer.
@ast
Exisulind in the treatment of prostate cancer.
@en
type
label
Exisulind in the treatment of prostate cancer.
@ast
Exisulind in the treatment of prostate cancer.
@en
prefLabel
Exisulind in the treatment of prostate cancer.
@ast
Exisulind in the treatment of prostate cancer.
@en
P2860
P356
P1476
Exisulind in the treatment of prostate cancer.
@en
P2093
Bradley C Leibovich
W Scott Webster
P2860
P304
P356
10.1586/14737140.5.6.957
P577
2005-12-01T00:00:00Z